Company Filing History:
Years Active: 2006-2009
Title: Holger Hoffmann: Innovator in Cancer Treatment
Introduction
Holger Hoffmann is a notable inventor based in Heppenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bengamide derivatives for cancer treatment. With a total of 2 patents, Hoffmann's work is paving the way for innovative therapeutic solutions.
Latest Patents
Hoffmann's latest patents focus on bengamide derivatives, which are formed during fermentation by the microorganism ST200611 (DSM 15898). These derivatives are being explored for their potential use in treating cancer diseases. The patents detail a process for preparing these compounds and their incorporation into pharmaceuticals aimed at combating cancer.
Career Highlights
Holger Hoffmann is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to improving treatment options for serious health conditions.
Collaborations
Hoffmann collaborates with esteemed colleagues, including Sabine Haag-Richter and Heiko Tietgen, who contribute to his research endeavors and help drive forward the development of new therapeutic agents.
Conclusion
Holger Hoffmann's contributions to the field of cancer treatment through his innovative patents highlight the importance of research and collaboration in the pharmaceutical industry. His work exemplifies the potential of scientific advancements to improve patient outcomes.